Madrigal Pharmaceuticals (MDGL) Non-cash Items (2012 - 2019)

Madrigal Pharmaceuticals (MDGL) has 8 years of Non-cash Items data on file, last reported at $673303.0 in Q1 2019.

• Non-cash Items for Q1 2019 came in at $673303.0, up 55.96% year-over-year; the trailing twelve-month figure through Mar 2019 was $673303.0 (up 55.96% YoY), and the FY2018 annual result was $89.1 million, up 22376.2% from the prior year.
• Non-cash Items slipped to $673303.0 in Q1 2019 per MDGL's latest filing, from $89.1 million in the prior quarter.
• Over five years, Non-cash Items peaked at $89.1 million in Q4 2018 and troughed at $146668.0 in Q4 2016.
• A 5-year average of $7.1 million and a median of $621000.0 in 2018 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2016 and 2018: Non-cash Items sank 97.41% in 2016, then surged 22376.2% in 2018.
• A 5-year view of Non-cash Items shows it stood at $5.7 million in 2015, then slumped by 97.41% to $146668.0 in 2016, then soared by 170.24% to $396357.0 in 2017, then surged by 22376.2% to $89.1 million in 2018, then slumped by 99.24% to $673303.0 in 2019.
• Business Quant data shows MDGL's Non-cash Items at $673303.0 in Q1 2019, $89.1 million in Q4 2018, and $621000.0 in Q3 2018.